The money in women's health goes to fertility, maternity and menopause. Nobody is built for women living with heart, kidney and metabolic disease — the leading cause of death in women. We are: the risk layer no model has, a generated 12-month care plan, and a member experience that starts with a text.
Every row is a transition point where heart, kidney or metabolic risk changes — and each has a diagnostic and a reimbursement path that exists today.
Told she's fine at six weeks. Twelve paid months of postpartum coverage in nearly every state, and no one uses them for her heart and kidneys.
Prior gestational diabetes or PCOS with a prediabetic A1c. Caught now it's prevention; caught at 55 it's diabetic kidney disease.
The standard kidney test overestimates women's kidney function. Early-stage disease is routinely missed, especially after preeclampsia or with autoimmune disease.
Blood pressure, cholesterol and blood sugar climb together and are rarely watched as one picture. Her employer already bought the menopause benefit; this is the other half.
Higher stroke risk than men at the same score, less likely to get a blood thinner. Add kidney disease and the decision nobody is making gets harder.
Majority female, called untreatable until recently, now responsive to one drug class that helps heart, kidney and diabetes at once. The triad, one plan.
Finds her in the plan's or employer's data: pregnancy history, menopause signal, a rhythm problem with no blood thinner, kidney numbers nobody coded.
A text with a link. Her plan in plain language. A cuff, patch or glucose meter at the door. Consent captured on the call.
A virtual visit. Remote ultrasound, rhythm patch, labs. Guideline medicines started. The care she wasn't getting.
Blood pressure, weight, rhythm flowing daily. Reimbursed monitoring. A nurse sees anything that crosses a threshold.
Readings flow back into the engine. She's re-ranked overnight. The next step is queued. The loop closes.
Every enrolled member gets a link. What she sees is her plan in plain words, never a probability or a score: why we reached out, her heart, kidneys and blood sugar as one picture, the one thing that matters this month, and a twenty-second reading each morning that her nurse actually reads.
During your pregnancy your blood pressure ran high. That can affect your heart and kidneys in the months after delivery, and it's the time when watching closely matters most. Alma, a nurse here, would like to keep an eye on it with you.
Heart, kidney and metabolic disease are one disease — the American Heart Association said so in 2023. Every tool in healthcare still scores them one at a time. CKMgraph scores them as a system, for every patient in a plan, an ACO or a panel. Women's CKM Health is the first program built on it.
A knowledge graph of the CKM syndrome — conditions, medications, biomarkers and the weighted, sourced edges between them. The patient with heart failure, stage 3b kidney disease and an A1c of 9 is one patient, not three flags.
Her trajectory matched against a corpus of care journeys to flag the path toward an admission or a stage progression, and to set the cadence of her plan.
Every indicated medication, every contraindication checked across the full CKM profile, ranked by what's closable — the missing blood thinner, the drug that protects heart and kidney at once.
Nearly every state now covers twelve months postpartum. Cardiovascular disease is the leading cause of maternal death. This is the program that fills the paid window.
AFib, heart failure and kidney disease are where the members and the medical cost are. Strokes and admissions avoided; BP control and statin measures moved.
The identify step upstream of the referral: which attributed lives get touched first, in what order, and why. Feeds any care team via API.
The cardiovascular-kidney-metabolic half of the menopause benefit nobody sells. Bolt-on to what's already bought.
A walkthrough of the program, the care team's workflow, and what the member sees — tailored to your population and your lines of business.